Hip DAA Closure Techniques

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

172 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-01

Study Completion Date

2024-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to analyze the difference in rates of wound complications using two different closure techniques in Direct anterior approach for primary total hip replacement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

HIP-STITCH (Wound Recovery After THA)

NCT06275776

Wound Healing Disturbance of

RECRUITING NA

Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)

NCT06831045

THA

RECRUITING NA

Occlusive Skin Closure May Reduce Wound Drainage After Tumor Hip Arthroplasty

NCT03746717

Metastatic Bone Disease of the Proximal Femur

COMPLETED NA

The Use of Barbed Sutures in Total Hip Arthroplasty

NCT02609464

Osteoarthritis, Hip

COMPLETED NA

Wound Healing in Primary TKA

NCT06007599

Total Knee Replacement Wound Complication

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The use of the direct anterior approach (DAA) for primary total hip arthroplasty (THA) has been increasingly popular but there has been a reported increased risk of wound complications compared with a posterior approach. Wound complications can lead to increased length of stay, reoperation procedures (i.e., irrigation and debridement), patient dissatisfaction, extra visits, readmissions, increased risk of periprosthetic joint infection and overall increased costs.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Hip Replacement Wound Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive

After surgery, the closure technique utilized by the surgeons will be wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive

Group Type ACTIVE_COMPARATOR

wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive

Intervention Type PROCEDURE

wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive

wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

After surgery, the closure technique utilized by the surgeons will be wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

Group Type ACTIVE_COMPARATOR

wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

Intervention Type PROCEDURE

wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

wound closure subcuticular running stitch using 3-0 monocryl suture without skin adhesive

Intervention Type PROCEDURE

wound closure subcuticular running stitch using 3-0 monocryl suture with two layers of skin adhesive

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients older than 18 years old that will undergo THA via DAA

Exclusion Criteria

* Previous hip arthroplasty surgeries or scars
* THA secondary to oncologic or traumatic etiologies
* BMI ≥ 40
* uncontrolled diabetes (measured by a Hgb A1c above 8)
* reported allergy to skin adhesive

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes